Fig. 1From: Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trialFlow chart of the procedures used in this study. Participants will be randomized (1:1 allocation ratio) into a basic nursing care with topical steroid treatment group or a basic nursing care with placebo control groupBack to article page